SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 59 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q1 2018$17,000
-29.2%
52,131
+11.0%
0.01%
-28.6%
Q4 2017$24,000
-44.2%
46,981
+2.2%
0.01%
-50.0%
Q3 2017$43,000
+87.0%
45,981
+14.4%
0.01%
+75.0%
Q2 2017$23,000
+43.8%
40,181
+60.4%
0.01%
-11.1%
Q1 2017$16,0000.0%25,050
+16.2%
0.01%0.0%
Q4 2016$16,000
-23.8%
21,550
+75.9%
0.01%
-25.0%
Q3 2016$21,00012,2500.01%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,734,149$6,609,00011.59%
Third Security, LLC 13,238,268$22,770,0001.06%
MSD Partners, L.P. 3,118,402$5,364,0000.43%
EDMOND DE ROTHSCHILD (SUISSE) S.A. 290,000$499,0000.15%
BARD ASSOCIATES INC 93,299$160,0000.08%
FRANKLIN STREET ADVISORS INC /NC 126,000$217,0000.04%
BLAIR WILLIAM & CO/IL 1,998,886$3,438,0000.03%
HAMILTON LANE ADVISORS LLC 23,855$41,0000.02%
Sheaff Brock Investment Advisors, LLC 86,449$149,0000.02%
Rothschild Capital Partners, LLC 30,000$52,0000.02%
View complete list of SYNTHETIC BIOLOGICS INC shareholders